Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 2
1986 1
1988 2
1989 29
1990 5
1991 4
1992 28
1993 13
1994 18
1995 17
1996 28
1997 45
1998 42
1999 49
2000 52
2001 58
2002 74
2003 67
2004 83
2005 66
2006 69
2007 73
2008 56
2009 54
2010 43
2011 41
2012 38
2013 37
2014 26
2015 31
2016 18
2017 16
2018 17
2019 8
2020 7
2021 15
2022 7
2023 6
2024 7
2025 12
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,170 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular effects of paroxetine.
Kuhs H, Rudolf GA. Kuhs H, et al. Psychopharmacology (Berl). 1990;102(3):379-82. doi: 10.1007/BF02244107. Psychopharmacology (Berl). 1990. PMID: 2147517 Clinical Trial.
In a double-blind clinical study, electrocardiogram, blood pressure and systolic time intervals were measured in 40 depressive patients treated with either paroxetine (30 mg/day) or amitriptyline (150 mg/day) for 6 weeks. While amitriptyline significantly increased the hea …
In a double-blind clinical study, electrocardiogram, blood pressure and systolic time intervals were measured in 40 depressive patients trea …
Paroxetine in human milk.
Begg EJ, Duffull SB, Saunders DA, Buttimore RC, Ilett KF, Hackett LP, Yapp P, Wilson DA. Begg EJ, et al. Br J Clin Pharmacol. 1999 Aug;48(2):142-7. doi: 10.1046/j.1365-2125.1999.00992.x. Br J Clin Pharmacol. 1999. PMID: 10417489 Free PMC article. Clinical Trial.
AIMS: The primary aims of the study were to estimate the exposure of infants to paroxetine via breast milk and to determine the maternal milk:plasma ratio (M/P) of paroxetine. ...In one study, six nursing mothers who were being treated with paroxetine were st …
AIMS: The primary aims of the study were to estimate the exposure of infants to paroxetine via breast milk and to determine the mater …
Paroxetine in social phobia.
Mancini C, Ameringen MV. Mancini C, et al. J Clin Psychiatry. 1996 Nov;57(11):519-22. doi: 10.4088/jcp.v57n1103. J Clin Psychiatry. 1996. PMID: 8968300 Clinical Trial.
This study attempted to assess the efficacy of paroxetine, a new SSRI, in the treatment of social phobia. METHOD: Paroxetine was administered to 18 patients who had a primary DSM-III-R diagnosis of social phobia, generalized type (diagnosed by using the Structured C …
This study attempted to assess the efficacy of paroxetine, a new SSRI, in the treatment of social phobia. METHOD: Paroxetine w …
Efficacy studies of paroxetine in panic disorder.
Lydiard RB, Steiner M, Burnham D, Gergel I. Lydiard RB, et al. Psychopharmacol Bull. 1998;34(2):175-82. Psychopharmacol Bull. 1998. PMID: 9640997 Review.
This article reviews three pivotal studies assessing the efficacy of paroxetine for the treatment of panic disorder, and evaluates these studies for inclusion of those variables considered essential. ...
This article reviews three pivotal studies assessing the efficacy of paroxetine for the treatment of panic disorder, and evaluates th …
Paroxetine is an effective treatment for refractory erythema of rosacea: Primary results from the Prospective Rosacea Refractory Erythema Randomized Clinical Trial.
Wang B, Huang Y, Tang Y, Zhao Z, Shi W, Jian D, Liu F, Gao Q, Wang P, Yang J, Li L, Xie H, Li J. Wang B, et al. J Am Acad Dermatol. 2023 Jun;88(6):1300-1307. doi: 10.1016/j.jaad.2023.01.044. Epub 2023 Feb 15. J Am Acad Dermatol. 2023. PMID: 36806645 Clinical Trial.
The most reported adverse events associated with paroxetine were dizziness, lethargy, nausea, dyspepsia, and muscle tremors. LIMITATIONS: Only a single-dosage regimen of paroxetine within a 12-week study was evaluated. CONCLUSIONS: Paroxetine is an effective …
The most reported adverse events associated with paroxetine were dizziness, lethargy, nausea, dyspepsia, and muscle tremors. LIMITATI …
Effects of paroxetine on human sleep.
Oswald I, Adam K. Oswald I, et al. Br J Clin Pharmacol. 1986 Jul;22(1):97-9. Br J Clin Pharmacol. 1986. PMID: 2943309 Free PMC article. Clinical Trial.
In a first double-blind, balanced order study, 12 subjects, mean age 57 years, took placebos at bedtime on 2 nights, paroxetine 15 mg on 2 nights and paroxetine 30 mg on 2 nights. In a second study, 12 subjects, mean age 56 years, took placebos on 2 mornings and …
In a first double-blind, balanced order study, 12 subjects, mean age 57 years, took placebos at bedtime on 2 nights, paroxetine 15 mg …
Effect of paroxetine on the electrocardiogram.
Edwards JG, Goldie A, Papayanni-Papasthatis S. Edwards JG, et al. Psychopharmacology (Berl). 1989;97(1):96-8. doi: 10.1007/BF00443420. Psychopharmacology (Berl). 1989. PMID: 2523548 Clinical Trial.
The electrocardiographic effects of paroxetine have been studied. High speed electrocardiograms were recorded on 20 patients with major depression before and after 4 weeks' treatment with either paroxetine or placebo. ...No significant changes in blood pressure were …
The electrocardiographic effects of paroxetine have been studied. High speed electrocardiograms were recorded on 20 patients with maj …
Efficacy of Paroxetine as an Adjuvant Therapy in Rheumatoid Arthritis Patients: A Randomized Controlled Study.
Aldossary KM, Abdallah MS, Mosalam EM, Kamal N, Saif DS, Elsayed SA, Afifi N, Zakaraia HG, Khrieba MO, Bahaa MM. Aldossary KM, et al. Drug Des Devel Ther. 2025 Dec 30;19:11925-11939. doi: 10.2147/DDDT.S572677. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 41488752 Free PMC article. Clinical Trial.
METHODS: In this randomized, double-blind, clinical trial, one hundred patients were randomized in 1:1 ratio to receive either csDMARDs including methotrexate plus placebo (control group) or paroxetine (paroxetine group). The primary endpoint was the change in Disea …
METHODS: In this randomized, double-blind, clinical trial, one hundred patients were randomized in 1:1 ratio to receive either csDMARDs incl …
Adult night terrors and paroxetine.
Wilson SJ, Lillywhite AR, Potokar JP, Bell CJ, Nutt DJ. Wilson SJ, et al. Lancet. 1997 Jul 19;350(9072):185. doi: 10.1016/s0140-6736(05)62351-3. Lancet. 1997. PMID: 9250190 Clinical Trial. No abstract available.
Paroxetine in social anxiety disorder: a randomized placebo-controlled study.
Allgulander C. Allgulander C. Acta Psychiatr Scand. 1999 Sep;100(3):193-8. doi: 10.1111/j.1600-0447.1999.tb10845.x. Acta Psychiatr Scand. 1999. PMID: 10493085 Clinical Trial.
RESULTS: Significant differences in efficacy between treatments (intent-to-treat analysis: 44 subjects on paroxetine and 48 subjects on placebo) were noted after 4-6 weeks, increasing through the treatment period in the paroxetine group. Nine subjects on paroxeti …
RESULTS: Significant differences in efficacy between treatments (intent-to-treat analysis: 44 subjects on paroxetine and 48 subjects …
1,170 results